Follow the Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. - H Shs stock price and the full directors' dealings record of the company, a listed issuer based in Hong Kong. Shares are quoted on HK HK, under the oversight of HKEX. The latest transaction was disclosed on 24 June 2026 (Other). Among the most active insiders: FU HANG. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. is a company focused on the development and production of biopharmaceutical products based on genetics. It emphasizes innovation in the field of biological therapies and genetic medicines.